SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1

Wenlin Huang, Kayode K. Ojo, Zhongsheng Zhang, Kasey Rivas, Rama Subba Rao Vidadala, Suzanne Scheele, Amy E. Derocher, Ryan Choi, Matthew A. Hulverson, Lynn K. Barrett, Igor Bruzual, Latha Kallur Siddaramaiah, Keshia M. Kerchner, Matthew D. Kurnick, Gail M. Freiberg, Dale Kempf, Wim G J Hol, Ethan A. Merritt, Georg Neckermann, Eugenio L. De HostosNina Isoherranen, Dustin J. Maly, Marilyn Parsons, Joseph Doggett, Wesley C. Van Voorhis, Erkang Fan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We previously discovered compounds based on a 5-aminopyrazole-4-carboxamide scaffold to be potent and selective inhibitors of CDPK1 from T. gondii. The current work, through structure-activity relationship studies, led to the discovery of compounds (34 and 35) with improved characteristics over the starting inhibitor 1 in terms of solubility, plasma exposure after oral administration in mice, or efficacy on parasite growth inhibition. Compounds 34 and 35 were further demonstrated to be more effective than 1 in a mouse infection model and markedly reduced the amount of T. gondii in the brain, spleen, and peritoneal fluid, and 35 given at 20 mg/kg eliminated T. gondii from the peritoneal fluid.

Original languageEnglish (US)
Pages (from-to)1184-1189
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume6
Issue number12
DOIs
StatePublished - Dec 10 2015
Externally publishedYes

Fingerprint

Toxoplasma
Ascitic Fluid
Fluids
Scaffolds
Brain
Solubility
Structure-Activity Relationship
Plasmas
Oral Administration
Parasites
Spleen
Growth
Infection
5-aminopyrazole

Keywords

  • calcium-dependent protein kinase-1
  • enzyme inhibitor
  • structure-activity relationship studies
  • Toxoplasma gondii

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1. / Huang, Wenlin; Ojo, Kayode K.; Zhang, Zhongsheng; Rivas, Kasey; Vidadala, Rama Subba Rao; Scheele, Suzanne; Derocher, Amy E.; Choi, Ryan; Hulverson, Matthew A.; Barrett, Lynn K.; Bruzual, Igor; Siddaramaiah, Latha Kallur; Kerchner, Keshia M.; Kurnick, Matthew D.; Freiberg, Gail M.; Kempf, Dale; Hol, Wim G J; Merritt, Ethan A.; Neckermann, Georg; De Hostos, Eugenio L.; Isoherranen, Nina; Maly, Dustin J.; Parsons, Marilyn; Doggett, Joseph; Van Voorhis, Wesley C.; Fan, Erkang.

In: ACS Medicinal Chemistry Letters, Vol. 6, No. 12, 10.12.2015, p. 1184-1189.

Research output: Contribution to journalArticle

Huang, W, Ojo, KK, Zhang, Z, Rivas, K, Vidadala, RSR, Scheele, S, Derocher, AE, Choi, R, Hulverson, MA, Barrett, LK, Bruzual, I, Siddaramaiah, LK, Kerchner, KM, Kurnick, MD, Freiberg, GM, Kempf, D, Hol, WGJ, Merritt, EA, Neckermann, G, De Hostos, EL, Isoherranen, N, Maly, DJ, Parsons, M, Doggett, J, Van Voorhis, WC & Fan, E 2015, 'SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1', ACS Medicinal Chemistry Letters, vol. 6, no. 12, pp. 1184-1189. https://doi.org/10.1021/acsmedchemlett.5b00319
Huang, Wenlin ; Ojo, Kayode K. ; Zhang, Zhongsheng ; Rivas, Kasey ; Vidadala, Rama Subba Rao ; Scheele, Suzanne ; Derocher, Amy E. ; Choi, Ryan ; Hulverson, Matthew A. ; Barrett, Lynn K. ; Bruzual, Igor ; Siddaramaiah, Latha Kallur ; Kerchner, Keshia M. ; Kurnick, Matthew D. ; Freiberg, Gail M. ; Kempf, Dale ; Hol, Wim G J ; Merritt, Ethan A. ; Neckermann, Georg ; De Hostos, Eugenio L. ; Isoherranen, Nina ; Maly, Dustin J. ; Parsons, Marilyn ; Doggett, Joseph ; Van Voorhis, Wesley C. ; Fan, Erkang. / SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1. In: ACS Medicinal Chemistry Letters. 2015 ; Vol. 6, No. 12. pp. 1184-1189.
@article{8fb2a8e875ae40b7b1af4da6cf6c712a,
title = "SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1",
abstract = "We previously discovered compounds based on a 5-aminopyrazole-4-carboxamide scaffold to be potent and selective inhibitors of CDPK1 from T. gondii. The current work, through structure-activity relationship studies, led to the discovery of compounds (34 and 35) with improved characteristics over the starting inhibitor 1 in terms of solubility, plasma exposure after oral administration in mice, or efficacy on parasite growth inhibition. Compounds 34 and 35 were further demonstrated to be more effective than 1 in a mouse infection model and markedly reduced the amount of T. gondii in the brain, spleen, and peritoneal fluid, and 35 given at 20 mg/kg eliminated T. gondii from the peritoneal fluid.",
keywords = "calcium-dependent protein kinase-1, enzyme inhibitor, structure-activity relationship studies, Toxoplasma gondii",
author = "Wenlin Huang and Ojo, {Kayode K.} and Zhongsheng Zhang and Kasey Rivas and Vidadala, {Rama Subba Rao} and Suzanne Scheele and Derocher, {Amy E.} and Ryan Choi and Hulverson, {Matthew A.} and Barrett, {Lynn K.} and Igor Bruzual and Siddaramaiah, {Latha Kallur} and Kerchner, {Keshia M.} and Kurnick, {Matthew D.} and Freiberg, {Gail M.} and Dale Kempf and Hol, {Wim G J} and Merritt, {Ethan A.} and Georg Neckermann and {De Hostos}, {Eugenio L.} and Nina Isoherranen and Maly, {Dustin J.} and Marilyn Parsons and Joseph Doggett and {Van Voorhis}, {Wesley C.} and Erkang Fan",
year = "2015",
month = "12",
day = "10",
doi = "10.1021/acsmedchemlett.5b00319",
language = "English (US)",
volume = "6",
pages = "1184--1189",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1

AU - Huang, Wenlin

AU - Ojo, Kayode K.

AU - Zhang, Zhongsheng

AU - Rivas, Kasey

AU - Vidadala, Rama Subba Rao

AU - Scheele, Suzanne

AU - Derocher, Amy E.

AU - Choi, Ryan

AU - Hulverson, Matthew A.

AU - Barrett, Lynn K.

AU - Bruzual, Igor

AU - Siddaramaiah, Latha Kallur

AU - Kerchner, Keshia M.

AU - Kurnick, Matthew D.

AU - Freiberg, Gail M.

AU - Kempf, Dale

AU - Hol, Wim G J

AU - Merritt, Ethan A.

AU - Neckermann, Georg

AU - De Hostos, Eugenio L.

AU - Isoherranen, Nina

AU - Maly, Dustin J.

AU - Parsons, Marilyn

AU - Doggett, Joseph

AU - Van Voorhis, Wesley C.

AU - Fan, Erkang

PY - 2015/12/10

Y1 - 2015/12/10

N2 - We previously discovered compounds based on a 5-aminopyrazole-4-carboxamide scaffold to be potent and selective inhibitors of CDPK1 from T. gondii. The current work, through structure-activity relationship studies, led to the discovery of compounds (34 and 35) with improved characteristics over the starting inhibitor 1 in terms of solubility, plasma exposure after oral administration in mice, or efficacy on parasite growth inhibition. Compounds 34 and 35 were further demonstrated to be more effective than 1 in a mouse infection model and markedly reduced the amount of T. gondii in the brain, spleen, and peritoneal fluid, and 35 given at 20 mg/kg eliminated T. gondii from the peritoneal fluid.

AB - We previously discovered compounds based on a 5-aminopyrazole-4-carboxamide scaffold to be potent and selective inhibitors of CDPK1 from T. gondii. The current work, through structure-activity relationship studies, led to the discovery of compounds (34 and 35) with improved characteristics over the starting inhibitor 1 in terms of solubility, plasma exposure after oral administration in mice, or efficacy on parasite growth inhibition. Compounds 34 and 35 were further demonstrated to be more effective than 1 in a mouse infection model and markedly reduced the amount of T. gondii in the brain, spleen, and peritoneal fluid, and 35 given at 20 mg/kg eliminated T. gondii from the peritoneal fluid.

KW - calcium-dependent protein kinase-1

KW - enzyme inhibitor

KW - structure-activity relationship studies

KW - Toxoplasma gondii

UR - http://www.scopus.com/inward/record.url?scp=84949757785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949757785&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.5b00319

DO - 10.1021/acsmedchemlett.5b00319

M3 - Article

AN - SCOPUS:84949757785

VL - 6

SP - 1184

EP - 1189

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 12

ER -